awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37346130-14FBA4C2-D7A7-4D02-9837-B3B8B4316F38
Q37346130-14FBA4C2-D7A7-4D02-9837-B3B8B4316F38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37346130-14FBA4C2-D7A7-4D02-9837-B3B8B4316F38
Design, statistical analysis and sample size calculation of a phase IIb/III study of linagliptin versus voglibose and placebo.
P2860
Q37346130-14FBA4C2-D7A7-4D02-9837-B3B8B4316F38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37346130-14FBA4C2-D7A7-4D02-9837-B3B8B4316F38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82c63210516b0a207d13701ed43f5bcc6829c721
P2860
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared wi